- Quantitative and targeted proteomics-based identification and validation of drug efficacy biomarkers
Takeshi Masuda et al, 2021, Drug Metabolism and Pharmacokinetics CrossRef - Clinical implications of the preoperative lymphocyte C-reactive protein ratio in esophageal cancer patients
Akira Yamamoto et al, 2021, Surgery Today CrossRef - Leucine-Rich Alpha-2-Glycoprotein 1 in Serum Is a Possible Biomarker to Predict Response to Preoperative Chemoradiotherapy for Esophageal Cancer
Madoka Nambu et al, 2019, Biological and Pharmaceutical Bulletin CrossRef - High postoperative monocyte indicates inferior Clinicopathological characteristics and worse prognosis in lung adenocarcinoma or squamous cell carcinoma after lobectomy
Yang Hai et al, 2018, BMC Cancer CrossRef - Ribophorin II promotes cell proliferation, migration, and invasion in esophageal cancer cells in vitro and in vivo
Yongshun Li et al, 2019, Bioscience Reports CrossRef - C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
Peter C. Hart et al, 2020, Frontiers in Immunology CrossRef - The Application of Nimotuzumab Combined With Definitive Chemoradiotherapy Toward the Treatment of Locally Advanced Cervical Esophageal Carcinoma: A Retrospective Study
Jing Hu et al, 2022, Frontiers in Oncology CrossRef - Diagnostic Utility of Neutrophil - Lymphocyte Ratio in Head and Neck Cancers
Sridhar Reddy Erugula et al, 2020, Journal of Evidence Based Medicine and Healthcare CrossRef - Changes in CRP and CA19-9 during Preoperative Oncological Therapy Predict Postoperative Survival in Pancreatic Ductal Adenocarcinoma
Anna Maria Nurmi et al, 2021, Oncology CrossRef - Circulating biomarkers of response to immunotherapy and immune-related adverse events
Zachary Garrison et al, 2022, Expert Review of Molecular Diagnostics CrossRef